Clinical Trial Update: Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the immune response in healthy individuals who had neonatal vaccination with Engerix-B; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2011-06-27